Suppr超能文献

多囊卵巢综合征或输卵管因素不孕症患者体外受精/卵胞浆内单精子注射结局的比较。

Comparison of IVF/ICSI outcome in patients with polycystic ovarian syndrome or tubal factor infertility.

作者信息

Okohue J E, Onuh S O, Ikimalo J I

机构信息

Gynescope Specialist Hospital, Port Harcourt, Rivers State, Nigeria.

出版信息

Niger J Clin Pract. 2013 Apr-Jun;16(2):207-10. doi: 10.4103/1119-3077.110164.

Abstract

BACKGROUND

One of the recognized treatment options for patients with polycystic ovarian syndrome (PCOS) is in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). Fears are however sometimes raised concerning the likely outcome of treatment in such patients compared with their counterparts with tubal factor infertility.

OBJECTIVE

To compare the IVF/ICSI performance in women with PCOS and those with tubal factor infertility.

MATERIALS AND METHODS

A retrospective analysis. Case notes of 30 patients, 35 years and below, with PCOS and who underwent 33 IVF/ICSI cycles and those of 42 age-controlled patients with tubal factor infertility and who had 43 cycles between December 2004 and April 2008 were retrieved. Data including duration of down-regulation, dose of human Menopausal Gonadotropin (hMG), number of cancelled treatments, endometrial thickness, number of oocytes retrieved and fertilization rate, in addition to the number of embryos transferred with resultant pregnancy outcome were compared between the two groups. The main outcome measures were response to gonadotropin stimulation, fertilization rate and clinical pregnancy rate.

RESULTS

There was no significant difference between the PCOS group and the tubal factor infertility group in the hMG dose (2.7 vs. 3.4 vials, respectively), endometrial thickness (10.5 vs. 10.1 mm, respectively) and embryos transferred (3.1 vs. 2.9, respectively). The fertilization rate was significantly higher in the tubal factor infertility group, which was 81.48% as against 63.24% for the PCOS group ( P < 0.0001). While more cases of ovarian hyperstimulation syndrome (OHSS) occurred in the PCOS group ( P = 0.049), overall clinical pregnancy rate per embryo transfer was similar (45.45% vs. 42.85%; P = 1), with similar miscarriage rates.

CONCLUSION

IVF/ICSI performance in patients with PCOS is probably similar to their counterparts with tubal factor infertility with, however, a reduced fertilization rate and higher incidence of OHSS.

摘要

背景

多囊卵巢综合征(PCOS)患者公认的治疗选择之一是体外受精(IVF)或卵胞浆内单精子注射(ICSI)。然而,与输卵管因素不孕的患者相比,有时人们会对这类患者治疗的可能结果感到担忧。

目的

比较PCOS女性与输卵管因素不孕女性的IVF/ICSI治疗效果。

材料与方法

一项回顾性分析。检索了2004年12月至2008年4月期间30例35岁及以下PCOS患者的病历记录,这些患者接受了33个IVF/ICSI周期治疗;以及42例年龄匹配的输卵管因素不孕患者的病历记录,这些患者进行了43个周期治疗。比较两组数据,包括降调节持续时间、人绝经期促性腺激素(hMG)剂量、取消治疗的次数、子宫内膜厚度、取出的卵母细胞数量和受精率,以及移植胚胎数量和最终妊娠结局。主要观察指标为对促性腺激素刺激的反应、受精率和临床妊娠率。

结果

PCOS组和输卵管因素不孕组在hMG剂量(分别为2.7瓶和3.4瓶)、子宫内膜厚度(分别为10.5mm和10.1mm)和移植胚胎数量(分别为3.1个和2.9个)方面无显著差异。输卵管因素不孕组的受精率显著更高,为81.48%,而PCOS组为63.24%(P<0.0001)。虽然PCOS组发生卵巢过度刺激综合征(OHSS)的病例更多(P=0.049),但每次胚胎移植的总体临床妊娠率相似(45.45%对42.85%;P=1),流产率也相似。

结论

PCOS患者的IVF/ICSI治疗效果可能与输卵管因素不孕患者相似,然而受精率较低且OHSS发生率较高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验